NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-085-2019-1-US-01 METHODS FOR ASSESSING CARDIOVASCULAR DISEASE OR INFLAMMATORY DISEASE RISK USING NON-EXCHANGEABLE LIPID PROBE US 62/844,957 Abandoned
NEI E-004-2017-0-US-03 3D VASCULARIZED HUMAN OCULAR TISSUE FOR CELL THERAPY AND DRUG DISCOVERY US National Stage 16/347,939 11458225 Issued PDF
NCI E-064-2019-0-US-01 CHIMERIC ANTIGEN RECEPTORS TARGETING GLYCIPAN-2 US 62/844,695 Abandoned
NCI E-169-2016-0-AU-03 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS AU National Stage 2017355564 Issued
NCI E-022-2017-0-US-04 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US National Stage 16/347,778 11312998 Issued PDF
NCI E-169-2016-0-US-06 DEVELOPMENT OF AGONIST EPITOPES OF THE HUMAN PAPILLOMAVIRUS US National Stage 16/347,764 11311613 Issued PDF
NCI E-022-2017-0-EP-03 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT EP National Stage 17805342.7 Issued
NCI E-022-2017-0-GB-08 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT GB EP 17805342.7 Issued
NCI E-022-2017-0-DE-07 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT DE EP 17805342.7 Issued
NCI E-022-2017-0-FR-06 METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT FR EP 17805342.7 Issued
NIAID E-357-2001-1-AU-31 WEST NILE VIRUS AND DENGUE 4 VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS AU DIV 2019203166 Expired
NCI E-123-2018-0-FR-01 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF FR EP 19724994.9 Issued
NCI E-123-2018-0-DE-01 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF DE EP 19724994.9 Issued
NCI E-123-2018-0-GB-01 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF GB EP 19724994.9 Issued
NCI E-123-2018-0-EP-03 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF EP National Stage 19724994.9 Issued
NEI E-293-2016-0-AU-04 TISSUE CLAMP AND IMPLANTATION METHOD AU National Stage 2017359336 Issued
NIAID E-239-2014-0-US-07 MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS IMMUNOGENS, ANTIBODIES, AND THEIR USE US DIV 16/403,211 10759846 Issued PDF
NCI E-123-2018-0-PCT-02 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF PCT PCT PCT/US2019/030656 Expired
NIAID E-087-2019-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 62/842,590 Abandoned
NIAID E-079-2018-0-PCT-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION PCT PCT COMB PCT/US2019/030431 Expired
NIAID E-079-2018-0-EP-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS, PREVENTION, AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION EP National Stage 19724039.3 Pending
NCI E-098-2018-0-PCT-02 T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR PCT PCT PCT/US2019/030108 Expired
NIEHS E-125-2018-2-CN-05 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS CN National Stage 201980029352.0 Issued
NIEHS E-125-2018-2-DE-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS DE EP 19723298.6 Issued
NIEHS E-125-2018-2-CH-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS CH EP 19723298.6 Issued
NIEHS E-125-2018-2-FR-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS FR EP 19723298.6 Issued
NIEHS E-125-2018-2-EP-03 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS EP National Stage 19723298.6 Issued
NIEHS E-125-2018-2-GB-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS GB EP 19723298.6 Issued
NHLBI E-287-2015-0-US-03 DEVICES AND METHODS FOR EFFECTUATING PERCUTANEOUS GLENN AND FONTAN PROCEDURES US CON 16/399,670 11179156 Issued PDF
NCI E-040-2012-0-AU-32 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU DIV 2019203042 Issued
NIEHS E-125-2018-2-PCT-01 USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN TREATING LUNG DISORDERS PCT PCT COMB PCT/US2019/29801 Expired
NCI E-103-2021-0-EP-01 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS EP DIV 23190055.6 Issued
NCI E-103-2021-0-PCT-02 USE OF LENTIVECTOR TRANSDUCED T-RAPA CELLS FOR AMELIORATION OF LYSOSOMAL STORAGE DISORDERS PCT PCT PCT/US2019/029639 Expired
NCI E-765-2013-0-US-08 MULTIFUNCTIONAL RNA NANOPARTICLES AND METHODS OF USE US CON 16/397,534 Abandoned
NHLBI E-112-2019-0-US-01 A Principal Component Analysis Based Multi-baseline Phase Correction Method For PRF Thermometry US 62/840,006 Abandoned
NHGRI E-176-2020-0-US-01 METHODS FOR TREATMENT OF SUBJECTS WITH PREEXISTING IMMUNITY US 62/829,771 Abandoned
NHGRI E-164-2020-1-US-01 METHODS AND COMPOSITIONS OF MMA CONSTRUCTS AND VECTORS US 62/839,761 Abandoned
NCI E-188-2016-0-US-03 STABLE WATER ISOTOPE LABELING AND MAGNETIC RESONANCE IMAGING FOR VISUALIZATION OF RAPIDLY DIVIDING CELLS US National Stage 16/345,612 11684306 Issued PDF
NIDCR E-142-2011-0-US-10 AAV MEDIATED EXENDIN-4 GENE TRANSFER TO SALIVARY GLANDS TO PROTECT SUBJECTS FROM DIABETES OR OBESITY US DIV 16/396,262 11207361 Issued PDF
NIMH E-126-2018-0-PCT-02 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF PCT PCT PCT/US2019/029285 Expired
NIMH E-126-2018-0-EP-04 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF EP National Stage 19722432.2 Abandoned
NCI E-173-2018-2-JP-06 Viral Methods Of T Cell Therapy JP National Stage 2019-522944 Abandoned
NIMH E-345-2013-0-AU-07 Monitoring The Effects Of Sleep Deprivation Using Neuronal Avalanches AU DIV 2019202928 Abandoned
NHLBI E-045-2018-0-JP-05 Vascular Anchoring Introducer Sheath JP National Stage 2019-545881 Issued
NHLBI E-045-2018-0-US-06 Vascular Anchoring Introducer Sheath US National Stage 16/394,182 11071535 Issued PDF
NINDS E-102-2019-0-US-01 HIGH-RESOLUTION CEREBROSPINAL FLUID-SUPPRESSED T2*-WEIGHTED MAGNETIC RESONANCE IMAGING OF CORTICAL LESIONS US 62/838,578 Abandoned
NIAID E-215-2016-1-US-03 PREFUSION PIV F IMMUNOGENS AND THEIR USE US National Stage 16/344,772 11078239 Issued PDF
NCI E-266-2011-0-HK-34 T Cell Receptors Recognizing HLA-A1-or HLA-CW7- Restricted Mage HK EP 19122845.1 Issued
NIAID E-234-2016-1-US-03 PREFUSION CORONAVIRUS SPIKE PROTEINS AND THEIR USE US National Stage 16/344,774 10960070 Issued PDF
NCATS E-060-2019-0-US-01 ANOCICEPTOR DIFFERENTIATION FROM HUMAN PLURIPOTENT STEM CELLS US 62/837,891 Abandoned